Shaking Up The Vegan Cheese Category Since 2004!
Shaking Up The Vegan Cheese Category Since 2004! Award-Winning Parma! Vegan Parmesan Offers Cheese Lovers A Delectably Nutritious Range of Dairy-Free, Protein-Rich Condiments Ideal For … Continue reading Shaking Up The Vegan Cheese Category Since 2004!
TENILLE TOWNES TAKES HOME FOUR WINS AT THE 2022 CCMA AWARDS PRESENTED BY TD
TENILLE TOWNES TAKES HOME FOUR WINS AT THE 2022 CCMA AWARDS PRESENTED BY TD TONIGHT’S WINS BRING TOWNES’ TOTAL TO FIVE, MAKING HER THE MOST AWARDED ARTIST OF THE YEAR Calgary, AB, Sept. 11, 2022 (GLOBE NEWSWIRE) — DALLAS SMITH CONTINUES STREAK WITH FOURTH MALE ARTIST OF THE YEAR WIN AND CELEBRATES WITH AMAZON MUSIC … Continue reading TENILLE TOWNES TAKES HOME FOUR WINS AT THE 2022 CCMA AWARDS PRESENTED BY TD
Tips for Avoiding the Fall 15… It’s not Just College Freshman- Adults Are Vulnerable to It as Well!
Tips for Avoiding the Fall 15… It’s not Just College Freshman- Adults Are Vulnerable to It as Well! www.drhaleyperlus.com If you have ever attended your freshman year at college or sent a child off to school, you are well acquainted with the term “freshman 15.” Those extra 15 pounds that creep on in the fall … Continue reading Tips for Avoiding the Fall 15… It’s not Just College Freshman- Adults Are Vulnerable to It as Well!
TELUS Health opens mental health support crisis line through LifeWorks for those affected by Saskatchewan tragedy
TELUS Health opens mental health support crisis line through LifeWorks for those affected by Saskatchewan tragedy 24/7 free crisis hotline now available to those in need at 1-844-751-2133 VANCOUVER, British Columbia, Sept. 07, 2022 (GLOBE NEWSWIRE) — TELUS Health has opened a free 24/7 crisis support hotline through LifeWorks to offer professional emotional support to … Continue reading TELUS Health opens mental health support crisis line through LifeWorks for those affected by Saskatchewan tragedy
Muvon Therapeutics Announces Successful Phase I Clinical Study in Female Patients with Stress Urinary Incontinence using a Novel Regenerative Cell Therapy`
Muvon Therapeutics Announces Successful Phase I Clinical Study in Female Patients with Stress Urinary Incontinence using a Novel Regenerative Cell Therapy Zurich, Switzerland, September 8, 2022 — Muvon Therapeutics AG, an innovative clinical-stage biotechnology company announced results from a Phase I clinical trial. This first study evaluating a proprietary cell therapy platform demonstrated the safety, feasibility … Continue reading Muvon Therapeutics Announces Successful Phase I Clinical Study in Female Patients with Stress Urinary Incontinence using a Novel Regenerative Cell Therapy`
